The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation

By Burnett Allison   Tiongson Jay   Downey Ross   Mahan Charles E  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1119-1133

Informa Healthcare

Access to resources Recommend Favorite

Anticoagulation for Non‐Valvular Atrial Fibrillation in Older People

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 3, 2012-09 ,pp. : 228-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation: Comparison of Decision Analytic Model Recommendations and Real-World Warfarin Prescription Use

By Casciano Julian P.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 313-323

Adis International

Access to resources Recommend Favorite

Relation of Low Vitamin D to Nonvalvular Persistent Atrial Fibrillation in Chinese Patients

By Chen Wei Ren   Liu Zhi Ying   Shi Yang   Yin Da Wei   Wang Hao   Sha Yuan   Chen Yun Dai  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 166-173

Blackwell Publishing

Access to resources Recommend Favorite

Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: New Insight in Selection of Rhythm or Rate Control Therapy and Impact of Mean Platelet Volume

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5824-5829

Bentham Science Publishers

Access to resources Recommend Favorite